196 related articles for article (PubMed ID: 25061833)
21. BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemia.
Press RD; Kamel-Reid S; Ang D
J Mol Diagn; 2013 Sep; 15(5):565-76. PubMed ID: 23810242
[TBL] [Abstract][Full Text] [Related]
22. Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory study.
Scott S; Cartwright A; Francis S; Whitby L; Sanzone AP; Mulder A; Galimberti S; Dulucq S; Mauté C; Lauricella C; Salmon M; Rose S; Willoughby J; Boeckx N; Pallisgaard N; Maier J; Leibundgut EO; Zizkova H; Ling Goh L; Duong C; Tang WF; Ma E; Shivakumar Y; Beppu L; Bhagavatula P; Chantry A
Br J Haematol; 2021 Jul; 194(1):53-60. PubMed ID: 34114218
[TBL] [Abstract][Full Text] [Related]
23. Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.
Brown JT; Beldorth IJ; Laosinchai-Wolf W; Fahey ME; Jefferson KL; Ruskin AK; Roth JJ; Cai L; Watt CD; Press RD; Yang F; Hedges JB; Andruss BF
J Mol Diagn; 2019 Jul; 21(4):718-733. PubMed ID: 31026597
[TBL] [Abstract][Full Text] [Related]
24. A pyrosequencing-based test for detection and relative quantification of the BCR-ABL1 T315I point mutation.
Schumacher JA; Szankasi P; Bahler DW; Ho AK; Kelley TW
J Clin Pathol; 2011 Jul; 64(7):618-25. PubMed ID: 21486895
[TBL] [Abstract][Full Text] [Related]
25. BCR-ABL1 transcript levels increase in peripheral blood but not in granulocytes after physical exercise in patients with chronic myeloid leukemia.
Jönsson S; Olsson B; Jacobsson S; Palmqvist L; Ricksten A; Ekeland-Sjöberg K; Wadenvik H
Scand J Clin Lab Invest; 2011 Feb; 71(1):7-11. PubMed ID: 20863169
[TBL] [Abstract][Full Text] [Related]
26. Cepheid xpert monitor platform for the confirmation of BCR-ABL1 IS conversion factors for the molecular monitoring of chronic myeloid leukaemia.
Gerrard G; Foong HE; Mudge K; Alikian M; Apperley JF; Foroni L
Leuk Res; 2016 Oct; 49():47-50. PubMed ID: 27552679
[TBL] [Abstract][Full Text] [Related]
27. Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories.
Müller MC; Erben P; Saglio G; Gottardi E; Nyvold CG; Schenk T; Ernst T; Lauber S; Kruth J; Hehlmann R; Hochhaus A;
Leukemia; 2008 Jan; 22(1):96-102. PubMed ID: 17943168
[TBL] [Abstract][Full Text] [Related]
28. Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practices.
Arora R; Press RD
Leuk Lymphoma; 2017 Jan; 58(1):8-16. PubMed ID: 27412040
[TBL] [Abstract][Full Text] [Related]
29. Measurement of BCR-ABL1 by RT-qPCR in chronic myeloid leukaemia: findings from an International EQA Programme.
Scott S; Travis D; Whitby L; Bainbridge J; Cross NCP; Barnett D
Br J Haematol; 2017 May; 177(3):414-422. PubMed ID: 28295199
[TBL] [Abstract][Full Text] [Related]
30. New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid Leukemia.
Badar T; Luthra R; Kantarjian H; Jabbour E; Borthakur G; Garcia-Manero G; Huang X; Singh R; Alvarez B; Austermiller B; Morrison TB; Patel KP; Cortes J
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):33-39. PubMed ID: 28682832
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia Patients.
Cortés AA; Olmedillas S; Serrano-López J; Lainez-González D; Castaño T; Iñiguez R; Lopez-Lorenzo JL; García A; Atance M; Sánchez RNS; Lopez CB; Arranz MG; Sillero PL; Alonso-Dominguez JM
Mol Diagn Ther; 2020 Oct; 24(5):593-600. PubMed ID: 32875515
[TBL] [Abstract][Full Text] [Related]
32. One-Step Multiplexed Droplet Digital Polymerase Chain Reaction for Quantification of p190 BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia.
Martinez RJ; Kang Q; Nennig D; Bailey NG; Brown NA; Betz BL; Tewari M; Thyagarajan B; Bachanova V; Mroz P
Arch Pathol Lab Med; 2022 Jan; 146(1):92-100. PubMed ID: 33769465
[TBL] [Abstract][Full Text] [Related]
33. Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group.
Iriyama N; Fujisawa S; Yoshida C; Wakita H; Chiba S; Okamoto S; Kawakami K; Takezako N; Kumagai T; Inokuchi K; Ohyashiki K; Taguchi J; Yano S; Igarashi T; Kouzai Y; Morita S; Sakamoto J; Sakamaki H
Am J Hematol; 2015 Apr; 90(4):282-7. PubMed ID: 25530131
[TBL] [Abstract][Full Text] [Related]
34. [A multicenter study on the revalidation of validated conversion factor for the conversion of BCRABL（P210）transcript levels to the international scale in chronic myeloid leukemia].
Qin Y; Ma D; Wang Y; Wang L; Wang Y; Liu S; Lu X; Li X; Cen J; Xiao M; Lin Z; Geng S; Liang C; Chen H; Han C; Han W; Huang X
Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):814-7. PubMed ID: 26477757
[TBL] [Abstract][Full Text] [Related]
35. Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR.
Jennings LJ; George D; Czech J; Yu M; Joseph L
J Mol Diagn; 2014 Mar; 16(2):174-9. PubMed ID: 24389534
[TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale.
Cross NC; White HE; Ernst T; Welden L; Dietz C; Saglio G; Mahon FX; Wong CC; Zheng D; Wong S; Wang SS; Akiki S; Albano F; Andrikovics H; Anwar J; Balatzenko G; Bendit I; Beveridge J; Boeckx N; Cerveira N; Cheng SM; Colomer D; Czurda S; Daraio F; Dulucq S; Eggen L; El Housni H; Gerrard G; Gniot M; Izzo B; Jacquin D; Janssen JJ; Jeromin S; Jurcek T; Kim DW; Machova-Polakova K; Martinez-Lopez J; McBean M; Mesanovic S; Mitterbauer-Hohendanner G; Mobtaker H; Mozziconacci MJ; Pajič T; Pallisgaard N; Panagiotidis P; Press RD; Qin YZ; Radich J; Sacha T; Touloumenidou T; Waits P; Wilkinson E; Zadro R; Müller MC; Hochhaus A; Branford S
Leukemia; 2016 Sep; 30(9):1844-52. PubMed ID: 27109508
[TBL] [Abstract][Full Text] [Related]
37. [Molecular analysis of the BCR-ABL1 fusion gene in a chronic myeloid leukemia patient with BCR-ABL1 International Scale-undetectable disease].
Kawamata N; Watanabe R
Rinsho Ketsueki; 2019; 60(7):767-772. PubMed ID: 31391364
[TBL] [Abstract][Full Text] [Related]
38. Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK.
Cross NCP; White HE; Evans PAS; Hancock J; Copland M; Milojkovic D; Mason J; Craine S; Mead AJ
Br J Haematol; 2018 Sep; 182(6):777-788. PubMed ID: 30125955
[TBL] [Abstract][Full Text] [Related]
39. Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR.
Ross DM; Branford S; Seymour JF; Schwarer AP; Arthur C; Bartley PA; Slader C; Field C; Dang P; Filshie RJ; Mills AK; Grigg AP; Melo JV; Hughes TP
Leukemia; 2010 Oct; 24(10):1719-24. PubMed ID: 20811403
[TBL] [Abstract][Full Text] [Related]
40. A multicenter investigation with D-FISH BCR/ABL1 probes.
Dewald G; Stallard R; Alsaadi A; Arnold S; Blough R; Ceperich TM; Rafael Elejalde B; Fink J; Higgins JV; Higgins RR; Hoeltge GA; Hsu WT; Johnson EB; Kronberger D; McCorquodale DJ; Meisner LF; Micale MA; Oseth L; Payne JS; Schwartz S; Sheldon S; Sophian A; Storto P; Van Tuinen P; Wenger GD; Wiktor A; Willis LA; Yung JF; Zenger-Hain J
Cancer Genet Cytogenet; 2000 Jan; 116(2):97-104. PubMed ID: 10640140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
